Oral Contraceptives

Oral treatment

Oral appliances

Oral Administration

Oral and Pharyngeal Disorders

AAPS PharmSciTech: Stability Enhancement of Drug Layered Pellets in a Fixed Dose Combination Tablet

Type: Original PaperThe purpose of this research was to develop a stable fixed dose combination tablet for a model DPP-IV inhibitor and metformin hydrochloride. The dipeptidyl peptidase IV (DPP-IV) in...

Impax Laboratories Announces Settlement of Litigation with Genzyme

Impax Laboratories, Inc. today announced that it has reached agreement with Genzyme, a Sanofi company, to settle pending U.S. litigation with regard to the production and sale of generic formulations...

Elite Pharma Announces Approval of Phentermine Capsules and Delayed Launch

Elite Pharmaceuticals, Inc. has announced that Elite received approval as of September 28th from the FDA for generic phentermine capsules 15 mg and 30 mg. Elite also announced that the sole supplier o...

Withdrawal Not a Problem with Phentermine (CME/CE)

(MedPage Today) -- Patients taking phentermine long-term to treat obesity don't have to worry about withdrawal when they come off it, researchers found.

Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced they have received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of Jenta...

HIV/AIDS Update - Prezista (darunavir) tablet and oral suspension: pediatric dosing

On February 1, 2013, FDA approved revisions to the Prezista (darunavir) tablet and oral suspension label to include once daily dosing in treatment-naïve subjects 3 to less than 18 years of age an...

Phentermine Returns for Weight Loss, But at a Low Dose

ECO 2012: Low-dose phentermine plus extended-release topiramate might help overweight and obese people lose weight, regardless of their obesity-related risk or the extent of their comorbidities. Med...

Impax Labs settles with Genzyme over Renvela and Renagel generics

USA-based Impax Laboratories (Nasdaq: IPXL) says it has reached agreement with French drug major Sanofi's (Euronext: SAN) biotech subsidiary Genzyme to settle pending US litigation with regard to the...

Preparation and in vivo evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet.

The objective of this study was to achieve an optimal formulation of spray dried matrix type controlled-release (MTCR) microparticles containing tamsulosin hydrochloride for orally disintegrating tabl...

Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form.

Objective: The objective of present investigation was to evaluate performance of cocrystals of Mefloquine Hydrochloride (MFL) in tablet dosage form. Our previous investigation showed significant effec...

A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults.

To evaluate safety and efficacy of phentermine 15 mg plus extended-release topiramate 92 mg for treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults.

Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up.

To study the release profiles of Ambroxol hydrochloride in matrix tablets with different fillers and controlled release materials, and investigate the potential impact on different fillers on the matr...

Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy.

PURPOSE: To characterize the pharmacokinetics (PK) of oxycodone following intravenous injection and administration of three oral dosage forms (solution, capsule, and controlled-release tablet) in elde...